R&D News | pharmaphorum

News

Novo Nordisk Foundation pledges €127m for cell therapy plant

The Novo Nordisk Foundation is funding the creation of a cell therapy development and manufacturing facility in Denmark with one of the largest investments in the sector i

News

Changes ring at Oxford Bio as ABL takeover talks progress

UK contract development and manufacturer organisation (CDMO) Oxford Biomedica confirmed this morning it is in talks that could result in the acquisition of rival ABL Europ

News

DeepMind applies its AI expertise to genetic diseases

Google’s DeepMind unit has used its artificial intelligence expertise to catalogue millions of ‘missense’ mutations in human DNA that may be related to the development of

News

Merck puts $1.3bn into AI via Exscientia, BenevolentAI deals

German group Merck has revved up its artificial intelligence-powered drug discovery with partnerships with two UK companies – Exscientia and BenevolentAI – that will focus

News

Novartis returns PD-1 antibody rights to BeiGene

BeiGene confirmed today that Novartis has pulled out of a partnership on PD-1 inhibitor tislelizumab, two and half years after paying $650 million upfront for ex-China rig

News

Older UK people back auto-enrolment in clinical trials

A new survey has found that a majority of people aged 50 or over in the UK who have long-term health conditions would have no problem with being automatically enrolled int

Novo Nordisk Foundation pledges €127m for cell therapy plant

Changes ring at Oxford Bio as ABL takeover talks progress

DeepMind applies its AI expertise to genetic diseases

Merck puts $1.3bn into AI via Exscientia, BenevolentAI deals

Novartis returns PD-1 antibody rights to BeiGene

Older UK people back auto-enrolment in clinical trials

Pharvaris plans filings for HAE drug after pivotal trial win

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks